Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nicholas Tilney

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Living Beings

Procedures

Chemicals & Drugs

Anatomy

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tilney Nicholas L
A statement from the transplantation society against organ trafficking and commerce in organs.
Desai S P; Desai M S; Wood D N; Maddi R; Leeson S; Tilney N L
A semi-centennial report on the participants depicted in Joel Babb's portrait, 'the first successful kidney transplantation'.
Perez Alexander; Ito Hiromichi; Farivar Robert S; Cohn Lawrence H; Byrne John G; Rawn James D; Aranki Sary F; Zinner Michael J; Tilney Nicholas L; Brooks David C; Ashley Stanley W; Banks Peter A; Whang Edward E
Risk factors and outcomes of pancreatitis after open heart surgery.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nicholas Tilney (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Tilney Nicholas L
A statement from the transplantation society against organ trafficking and commerce in organs.
Transplantation 2008;85(8):1067.
2007: Desai S P; Desai M S; Wood D N; Maddi R; Leeson S; Tilney N L
A semi-centennial report on the participants depicted in Joel Babb's portrait, 'the first successful kidney transplantation'.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(7):1683-8.
2005: Perez Alexander; Ito Hiromichi; Farivar Robert S; Cohn Lawrence H; Byrne John G; Rawn James D; Aranki Sary F; Zinner Michael J; Tilney Nicholas L; Brooks David C; Ashley Stanley W; Banks Peter A; Whang Edward E
Risk factors and outcomes of pancreatitis after open heart surgery.
American journal of surgery 2005;190(3):401-5.
2005: Gasser Martin; Waaga-Gasser Ana Maria; Grimm Michael W; Grimm Martin R; Lenhard Miriam S; Kist-van Holthe Joana E; Laskowski Igor; Shaw Gray D; Thiede Arnulf; Hancock Wayne W; Tilney Nicholas L
Selectin blockade plus therapy with low-dose sirolimus and cyclosporin a prevent brain death-induced renal allograft dysfunction.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(4 Pt 1):662-70.
2004: Pratschke Johann; Paz Dustin; Wilhelm Markus J; Laskowski Igor; Kofla Gregorz; Vergopoulos Athanasios; MacKenzie Harald J; Tullius Stefan G; Neuhaus Peter; Hancock Wayne W; Volk Hans-Dieter; Tilney Nicholas L
Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts.
Transplantation 2004;77(1):43-8.
2003: Tilney N L
The commercialization of transplantation.
Transplantation proceedings 2003;35(3):1235-7.
2002: Wilhelm M J; Pratschke J; Beato F; Taal M; Laskowski I A; Paz D M; Schmid C; Hancock W W; Scheld H H; Tilney N L
Activation of proinflammatory mediators in heart transplants from brain-dead donors: evidence from a model of chronic rat cardiac allograft rejection.
Transplantation proceedings 2002;34(6):2359-60.
2002: Pratschke J; Kofla G; Wilhelm M; Vergopoulos A; Laskowski I; Shaw G D; Tullius S G; Volk H D; Neuhous P; Tilney N L
Improvements in early behaviour of kidney allografts after donor treatment.
Transplantation proceedings 2002;34(6):2213-4.
2002: Kusaka Mamoru; Mackenzie Harald S; Ziai Farzard; Hancock Wayne W; Tilney Nicholas L
Recipient hypertension potentiates chronic functional and structural injury of rat renal allografts.
Transplantation 2002;74(3):307-14.
2002: Gasser Martin; Waaga Ana Maria; Kist-Van Holthe Joana E; Lenhard Susanne M; Laskowski Igor; Shaw Gray D; Hancock Wayne W; Tilney Nicholas L
Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand.
Journal of the American Society of Nephrology : JASN 2002;13(7):1937-45.
2002: Laskowski Igor A; Pratschke Johann; Wilhelm Marcus M; Gasser Martin; Paz Dustin; Hancock Wayne W; Tilney Nicholas L
Early and late injury to renal transplants from non-heart-beating donors.
Transplantation 2002;73(9):1468-73.
2002: Laskowski Igor A; Pratschke Johann; Wilhelm Markus J; Dong Victor M; Beato Francisca; Taal Maarten; Gasser Martin; Hancock Wayne W; Sayegh Mohamed H; Tilney Nicholas L
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats.
Journal of the American Society of Nephrology : JASN 2002;13(2):519-27.
2001: Pratschke J; Kofla G; Wilhelm M J; Vergopoulos A; Laskowski I; Shaw G D; Tullius S G; Volk H D; Neuhaus P; Tilney N L
Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor.
Annals of surgery 2001;234(6):732-40.
2001: Pratschke J; Wilhelm M J; Laskowski I; Kusaka M; Beato F; Tullius S G; Neuhaus P; Hancock W W; Tilney N L
Influence of donor brain death on chronic rejection of renal transplants in rats.
Journal of the American Society of Nephrology : JASN 2001;12(11):2474-81.
2001: Tilney N L; Guttmann R D; Daar A S; Hoffenberg R; Kennedy I; Lock M; Radcliffe-Richards J; Sells R A
The new chimaera: the industrialization of organ transplantation. International Forum for Transplant Ethics.
Transplantation 2001;71(5):591-3.
2001: Laskowski I A; Hancock W W; Pratchke J; Wilhelm M J; Tilney N L
Accelerated graft dysfunction in renal isografts from non-heart-beating donors.
Transplantation proceedings 2001;33(1-2):909-10.
2001: Kusaka M; Pratschke J; Wilhelm M J; Ziai F; Zandi-Nejad K; Mackenzie H S; Hancock W W; Tilney N L
Early and late inflammatory changes occurring in rat renal isografts from brain dead donors.
Transplantation proceedings 2001;33(1-2):867-8.
2001: Tilney N L; Paz D; Ames J; Gasser M; Laskowski I; Hancock W W
Ischemia-reperfusion injury.
Transplantation proceedings 2001;33(1-2):843-4.
2001: Pratschke J; Wilhelm M J; Laskowski I; Kusaka M; Paz D; Tullius S G; Neuhaus P; Hancock W W; Tilney N L
The influence of donor brain death on long-term function of renal allotransplants in rats.
Transplantation proceedings 2001;33(1-2):693-4.
2001: Laskowski I A; Pratschke J; Wilhelm M J; Paz D; Ames J B; Dong V M; Beato F; Sayegh M H; Hancock W W; Tilney N L
Prolongation of survival and preservation of allograft structure and function by a signaling CD28 mAB in a rat model of chronic kidney rejection.
Transplantation proceedings 2001;33(1-2):567-8.
2001: Wilhelm M J; Pratschke J; Laskowski I A; Paz D M; Hancock W W; Tilney N L
Altered alloimmune response toward grafts from brain-dead donors in chronic rat cardiac allograft rejection.
Transplantation proceedings 2001;33(1-2):366-7.
2001: Wilhelm M J; Pratschke J; Paz D M; Laskowski I A; Mackenzie H S; Hancock W W; Tilney N L
Donor hypertension and recipient immune responsiveness in chronic rat cardiac allograft rejection.
Transplantation proceedings 2001;33(1-2):321-2.
2000: Wilhelm M J; Pratschke J; Beato F; Taal M; Kusaka M; Hancock W W; Tilney N L
Activation of the heart by donor brain death accelerates acute rejection after transplantation.
Circulation 2000;102(19):2426-33.
2000: Tilney N L
Transplantation and its biology: from fantasy to routine.
Journal of applied physiology (Bethesda, Md. : 1985) 2000;89(5):1681-9.
2000: Waaga A M; Gasser M; Laskowski I; Tilney N L
Mechanisms of chronic rejection.
Current opinion in immunology 2000;12(5):517-21.
2000: Tilney N L
Triumph of hope over experience.
Transplantation 2000;70(4):706-7.
2000: Pratschke J; Wilhelm M J; Kusaka M; Beato F; Milford E L; Hancock W W; Tilney N L
Accelerated rejection of renal allografts from brain-dead donors.
Annals of surgery 2000;232(2):263-71.
2000: Ziai F; Nagano H; Kusaka M; Coito A J; Troy J L; Nadeau K C; Rennke H G; Tilney N L; Brenner B M; MacKenzie H S
Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines.
Kidney international 2000;57(6):2618-25.
2000: Wilhelm M J; Pratschke J; Laskowski I A; Paz D M; Tilney N L
Brain death and its impact on the donor heart-lessons from animal models.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(5):414-8.
2000: Pratschke J; Wilhelm M J; Kusaka M; Laskowski I; Tilney N L
A model of gradual onset brain death for transplant-associated studies in rats.
Transplantation 2000;69(3):427-30.
2000: Kusaka M; Pratschke J; Wilhelm M J; Ziai F; Zandi-Nejad K; Mackenzie H S; Hancock W W; Tilney N L
Activation of inflammatory mediators in rat renal isografts by donor brain death.
Transplantation 2000;69(3):405-10.
2000: Gasser M; Waaga A M; Laskowski I A; Tilney N L
The influence of donor brain death on short and long-term outcome of solid organ allografts.
Annals of transplantation : quarterly of the Polish Transplantation Society 2000;5(4):61-7.
2000: Laskowski I; Pratschke J; Wilhelm M J; Gasser M; Tilney N L
Molecular and cellular events associated with ischemia/reperfusion injury.
Annals of transplantation : quarterly of the Polish Transplantation Society 2000;5(4):29-35.
1999: Hendry W S; Tilney N L; Baldwin W M; Graves M J; Milford E; Strom T B; Carpenter C B
Transfer of specific unresponsiveness to organ allografts by thymocytes.
Journal of the American Society of Nephrology : JASN 1999;10(11):2454-63.
1999: Laskowski I A; Pratschke J; Wilhelm M J; Paz D; Tilney N L
Non-heartbeating kidney donors.
Clinical transplantation 1999;13(4):281-6.
1999: Kusaka M; Zandi-Nejad K; Kato S; Beato F; Nagano H; Shaw G D; Tilney N L
Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination.
Transplantation 1999;67(9):1255-61.
1999: Wilhelm M J; Pratschke J; Kusaka M; Hancock W W; Tilney N L
Donor brain death affects tempo and intensity of acute rejection of rat chronic allografts.
Transplantation proceedings 1999;31(1-2):1008-9.
1999: Pratschke J; Wilhelm M J; Kusaka M; Hancock W W; Tilney N L
Activation of proinflammatory genes in somatic organs as a consequence of brain death.
Transplantation proceedings 1999;31(1-2):1003-5.
1999: Pratschke J; Wilhelm M J; Kusaka M; Hancock W W; Tilney N L
Acute rejection of rat renal allografts is accelerated by donor brain death.
Transplantation proceedings 1999;31(1-2):874-5.
1999: Kusaka M; Ziai F; Hancock W W; Tilney N L; Mackenzie H S
Systemic hypertension accelerates chronic rejection of renal allografts in the rat.
Transplantation proceedings 1999;31(1-2):869.
1999: Nagano H; Tilney N L; Stinn J L; Becker G; Hasegawa S; Libby P; Mitchell R N
Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts.
Transplantation proceedings 1999;31(1-2):152.
1999: Tilney N L
Chronic rejection and its risk factors.
Transplantation proceedings 1999;31(1-2A):41S-44S.
1999: Pratschke J; Wilhelm M J; Kusaka M; Basker M; Cooper D K; Hancock W W; Tilney N L
Brain death and its influence on donor organ quality and outcome after transplantation.
Transplantation 1999;67(3):343-8.
1998: Wilhelm M J; Kusaka M; Pratschke J; Tilney N L
Chronic rejection: increasing evidence for the importance of allogen-independent factors.
Transplantation proceedings 1998;30(5):2402-6.
1998: Takada M; Nadeau K C; Hancock W W; Mackenzie H S; Shaw G D; Waaga A M; Chandraker A; Sayegh M H; Tilney N L
Effects of explosive brain death on cytokine activation of peripheral organs in the rat.
Transplantation 1998;65(12):1533-42.
1998: Radcliffe-Richards J; Daar A S; Guttmann R D; Hoffenberg R; Kennedy I; Lock M; Sells R A; Tilney N
The case for allowing kidney sales. International Forum for Transplant Ethics.
Lancet 1998;351(9120):1950-2.
1998: Tilney N L; Kusaka M; Pratschke J; Wilhelm M
Chronic rejection.
Transplantation proceedings 1998;30(4):1590-4.
1998: Kusaka M; Nadeau K C; Takada M; Nagano H; Shaw G D; Tilney N L
Influence of initial antigen-independent events on acute allograft rejection: inhibition by a soluble P-selectin ligand and low-dose cyclosporine in combination.
Transplantation proceedings 1998;30(4):1027-8.
1998: Chandraker A; Azuma H; Nadeau K; Carpenter C B; Tilney N L; Hancock W W; Sayegh M H
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
The Journal of clinical investigation 1998;101(11):2309-18.
1998: Kennedy I; Sells R A; Daar A S; Guttmann R D; Hoffenberg R; Lock M; Radcliffe-Richards J; Tilney N
The case for "presumed consent" in organ donation. International Forum for Transplant Ethics.
Lancet 1998;351(9116):1650-2.
1998: Nagano H; Libby P; Taylor M K; Hasegawa S; Stinn J L; Becker G; Tilney N L; Mitchell R N
Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
The American journal of pathology 1998;152(5):1187-97.
1997: Mackenzie H S; Ziai F; Nagano H; Azuma H; Troy J L; Rennke H G; Tilney N L; Brenner B M
Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(6):S21-5.
1997: Nagano H; Nadeau K C; Kusaka M; Heeman U W; Tilney N L
Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats.
Transplantation 1997;64(11):1602-5.
1997: Takada M; Nadeau K C; Shaw G D; Tilney N L
Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding.
Transplantation 1997;64(11):1520-5.
1997: Chandraker A; Takada M; Nadeau K C; Peach R; Tilney N L; Sayegh M H
CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury.
Kidney international 1997;52(6):1678-84.
1997: Hoffenberg R; Lock M; Tilney N; Casabona C; Daar A S; Guttmann R D; Kennedy I; Nundy S; Radcliffe-Richards J; Sells R A
Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics.
Lancet 1997;350(9087):1320-1.
1997: Tilney N L; Guttmann R D
Effects of initial ischemia/reperfusion injury on the transplanted kidney.
Transplantation 1997;64(7):945-7.
1997: Takada M; Chandraker A; Nadeau K C; Sayegh M H; Tilney N L
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.
The Journal of clinical investigation 1997;100(5):1199-203.
1997: Nagano H; Mitchell R N; Taylor M K; Hasegawa S; Tilney N L; Libby P
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts.
The Journal of clinical investigation 1997;100(3):550-7.
1997: Azuma H; Nadeau K; Takada M; Mackenzie H S; Tilney N L
Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.
Transplantation 1997;64(2):190-7.
1997: Takada M; Nadeau K C; Shaw G D; Marquette K A; Tilney N L
The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.
The Journal of clinical investigation 1997;99(11):2682-90.
1997: Nagano H; Tilney N L
Chronic allograft failure: the clinical problem.
The American journal of the medical sciences 1997;313(5):305-9.
1997: Nagano H; Nadeau K C; Takada M; Kusaka M; Tilney N L
Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats.
Transplantation 1997;63(8):1101-8.
1997: Azuma H; Nadeau K; Takada M; Tilney N L
Initial ischemia/reperfusion injury influences late functional and structural changes in the kidney.
Transplantation proceedings 1997;29(1-2):1528-9.
1997: Takada M; Nadeau K C; Shaw G D; Tilney N L
Early cellular and molecular changes in ischemia/reperfusion injury: inhibition by a selectin antagonist, P-selectin glycoprotein ligand-1.
Transplantation proceedings 1997;29(1-2):1324-5.
1997: Nadeau K; Azuma H; Chandraker A; Sayegh M H; Tilney N L
Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
Transplantation proceedings 1997;29(1-2):1038.
1997: Azuma H; Nadeau K; Mackenzie H S; Brenner B M; Tilney N L
Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft.
Transplantation 1997;63(4):519-28.
1997: Stelzner M; Vlahakos D V; Milford E L; Tilney N L
Colonic perforations after renal transplantation.
Journal of the American College of Surgeons 1997;184(1):63-9.
1996: Nadeau K C; Azuma H; Tilney N L
Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil.
Transplantation 1996;62(9):1363-6.
1996: Azuma H; Chandraker A; Nadeau K; Hancock W W; Carpenter C B; Tilney N L; Sayegh M H
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(22):12439-44.
1996: Azuma H; Paul L C; Tilney N L
Insights into acute and chronic rejection.
Transplantation proceedings 1996;28(4):2081-4.
1996: Schmid C; Heemann U; Tilney N L
Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection.
Transplantation 1996;61(12):1695-9.
1996: Mackenzie H S; Azuma H; Troy J L; Rennke H G; Tilney N L; Brenner B M
Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats.
Proceedings of the Association of American Physicians 1996;108(2):127-33.
1995: Azuma H; Nadeau K C; Ishibashi M; Tilney N L
Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor.
Transplantation 1995;60(12):1577-82.
1995: Azuma H; Tilney N L
Immune and nonimmune mechanisms of chronic rejection of kidney allografts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1995;14(6 Pt 2):S136-42.
1995: Schmid C; Heemann U; Azuma H; Tilney N L
Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
Transplantation 1995;60(7):729-33.
1995: Nadeau K C; Azuma H; Tilney N L
Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(19):8729-33.
1995: Tullius S G; Heemann U W; Azuma H; Pradham P; Tilney N L
Characteristic signs of chronic allograft rejection can be observed in mechanically manipulated naive rat kidneys over the long-term.
Transplantation proceedings 1995;27(3):2131-2.
1995: Tilney N L
Thoughts on the immunobiology of chronic allograft rejection.
Transplantation proceedings 1995;27(3):2123-5.
1995: Schmid C; Heemann U; Azuma H; Tilney N L
Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and -independent factors.
Transplantation proceedings 1995;27(3):2077-9.
1995: Tullius S G; Heemann U W; Zeilinger K; Azuma H; Tamatami T; Miyasaka M; Tilney N L
Binding of lymphocytes to acutely rejecting rat kidney allografts in vitro is guided by events in the graft itself rather than by sensitization of host lymphocytes.
Transplant immunology 1995;3(2):91-7.
1995: Tullius S G; Heemann U W; Azuma H; Hancock W W; Pradham P; Tilney N L
Antigen-independent events mimic characteristic changes of chronic allograft rejection.
Transplantation proceedings 1995;27(1):561-3.
1995: Heemann U W; Azuma H; Tullius S G; Mackenzie H S; Schmid C; Brenner B M; Tilney N L
Influence of renal mass on chronic kidney allograft rejection in rats.
Transplantation proceedings 1995;27(1):549.
1995: Schmid C; Heemann U; Azuma H; Tilney N L
Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
Transplantation proceedings 1995;27(1):438-9.
1995: Azuma H; Binder J; Heemann U; Tullius S G; Tilney N L
Effect of RS61443 on chronic rejection of rat kidney allografts.
Transplantation proceedings 1995;27(1):436-7.
1995: Azuma H; Binder J; Heemann U; Schmid C; Tullius S G; Tilney N L
Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts.
Transplantation 1995;59(4):460-6.
1995: Tullius S G; Tilney N L
Both alloantigen-dependent and -independent factors influence chronic allograft rejection.
Transplantation 1995;59(3):313-8.
1994: Heemann U W; Azuma H; Tullius S G; Mackenzie H; Brenner B M; Tilney N L
The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.
Transplantation 1994;58(12):1317-22.
1994: Mackenzie H S; Tullius S G; Heemann U W; Azuma H; Rennke H G; Brenner B M; Tilney N L
Nephron supply is a major determinant of long-term renal allograft outcome in rats.
The Journal of clinical investigation 1994;94(5):2148-52.
1994: Tullius S G; Heemann U; Hancock W W; Azuma H; Tilney N L
Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection.
Annals of surgery 1994;220(4):425-32; discussion 432-5.
1994: Azuma H; Tilney N L
Chronic graft rejection.
Current opinion in immunology 1994;6(5):770-6.
1994: Azuma H; Tullius S G; Heemann U W; Tilney N L
Nonimmune factors may contribute to chronic rejection of kidney transplants.
Transplantation proceedings 1994;26(4):2109-10.
1994: Heemann U W; Tullius S G; Azuma H; Mackenzie H S; Brenner B M; Tilney N L
Evidence for a beneficial effect of increased functional kidney mass upon chronic kidney rejection in rats.
Transplantation proceedings 1994;26(4):2047.
1994: Heemann U W; Tullius S G; Tamatami T; Miyasaka M; Milford E; Tilney N L
Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7(5):349-55.
1994: Tullius S G; Heemann U; Azuma H; Pradham P; Tilney N L
Early ischemic injury leads to long-term functional and morphologic deterioration of naive rat kidneys and may contribute to changes of chronic allograft rejection.
Transplantation proceedings 1994;26(4):2041-2.
1994: Tullius S G; Hancock W W; Heemann U; Azuma H; Tilney N L
Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury.
Transplantation 1994;58(1):93-9.
1994: Tilney N L; Schmid C; Azuma H; Heemann U W
Transplantation immunology: an introduction.
Transplant immunology 1994;2(2):99-102.
1994: Tilney N L
Transplantation--challenges for the future may be more philosophical than biological.
Transplant immunology 1994;2(2):166-8.
1994: Azuma H; Heemann U W; Tullius S G; Tilney N L
Cytokines and adhesion molecules in chronic rejection.
Clinical transplantation 1994;8(2 Pt 2):168-80.
1994: Heemann U W; Tullius S G; Azuma H; Kupiec-Weglinsky J; Tilney N L
Adhesion molecules and transplantation.
Annals of surgery 1994;219(1):4-12.
1994: Heemann U W; Tullius S G; Azuma H; Tilney N L
The relationship between reduced functioning kidney mass and chronic rejection in rats.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S328-30.
1994: Azuma H; Heemann U; Tullius S G; Tilney N L
Host leukocytes and their products in chronic kidney allograft rejection in rats.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S325-7.
1994: Tullius S G; Heemann U W; Azuma H; Hancock W W; Tilney N L
Alloantigen-independent factors lead to signs of chronic rejection in long-term kidney isografts.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S306-7.
1994: Schmid C; Binder J; Heemann U; Tilney N L
Successful heterotopic heart transplantation in rat.
Microsurgery 1994;15(4):279-81.
1993: Whitley W D; Hancock W W; Kupiec-Weglinski J W; DeSousa M; Tilney N L
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
Transplantation 1993;56(5):1182-8.
1993: Hancock W H; Whitley W D; Tullius S G; Heemann U W; Wasowska B; Baldwin W M; Tilney N L
Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts.
Transplantation 1993;56(3):643-50.
1993: Kupiec-Weglinski J W; Heemann U W; Coito A J; Tullius S G; Tilney N L; de Sousa M
Adhesion molecule interaction with extracellular matrix.
Experimental nephrology 1993;1(2):78-82.
1993: Heemann U W; Tullius S G; Schumann V; Tilney N L
Neutrophils and macrophages are prominent in the pathophysiology of chronic rejection of rat kidney allografts.
Transplantation proceedings 1993;25(1 Pt 2):937-8.
1993: Tullius S G; Heemann U W; Wagner K; Tilney N L
Changes of chronic kidney allograft rejection are reversible after retransplantation.
Transplantation proceedings 1993;25(1 Pt 2):906-7.
1993: Tilney N L; Whitley W D; Tullius S G; Heemann U W; Wasowska B; Baldwin W M; Hancock W W
Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model.
Transplantation proceedings 1993;25(1 Pt 2):861-2.
1992: Hancock W W; Whitley W D; Baldwin W M; Tilney N L
Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection.
Transplantation proceedings 1992;24(5):2315-6.
1992: Tanaka K; Tilney N L; Kupiec-Weglinski J W
Maturing thymocytes in accelerated rejection of cardiac allografts in presensitized rats.
Transplantation 1992;54(3):515-9.
1992: Sablinski T; Sayegh M H; Kut J P; Milford E L; Tilney N L; Kupiec-Weglinski J W
Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
Transplantation 1992;54(2):292-6.
1992: Adams D H; Tilney N L; Collins J J; Karnovsky M J
Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
Transplantation 1992;53(5):1115-9.
1992: Hancock W W; Whitley D; Kupiec-Weglinski J W; Tilney N L
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
Transplantation proceedings 1992;24(1):214-5.
1992: Sablinski T; Sayegh M H; Kut J P; Tilney N L; Milford E L; Kupiec-Weglinski J W
The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
Transplantation 1992;53(1):219-21.
1991: Sablinski T; Hancock W W; Tilney N L; Kupiec-Weglinski J W
CD4 monoclonal antibodies in organ transplantation--a review of progress.
Transplantation 1991;52(4):579-89.
1991: Ueda H; Cheung Y C; Masetti P; Diaco M; McCarter M; Kupiec-Weglinski J W; Tilney N L;
Synergy between cyclosporine and anti-IL-2 receptor monoclonal antibodies in rats. Functional studies of heart and kidney allografts.
Transplantation 1991;52(3):437-42.
1991: Tilney N L; Whitley W D; Diamond J R; Kupiec-Weglinski J W; Adams D H
Chronic rejection--an undefined conundrum.
Transplantation 1991;52(3):389-98.
1991: Tilney N L; Kupiec-Weglinski J W
The biology of acute transplant rejection.
Annals of surgery 1991;214(2):98-106.
1991: Tilney N L; Chang A; Milford E L; Whitley W D; Lazarus J M; Ramos E L; Strom T B; Carpenter C B; Kirkman R L
Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
Annals of surgery 1991;214(1):42-9.
1991: Sablinski T; Tilney N L
Ludwik Rydygier and the first gastrectomy for peptic ulcer.
Surgery, gynecology & obstetrics 1991;172(6):493-6.
1991: Kupiec-Weglinski J W; Sablinski T; Hancock W W; Mix C T; Tilney N L
Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):285-6.
1991: Sablinski T; Sayegh M H; Kut J P; Hancock W W; Milford E L; Tilney N L; Kupiec-Weglinski J W
Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
Transplantation proceedings 1991;23(1 Pt 1):268-9.
1991: Kirkman R L; Shapiro M E; Carpenter C B; McKay D B; Milford E L; Ramos E L; Tilney N L; Waldmann T A; Zimmerman C E; Strom T B
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1066-7.
1991: Snydman D R; Werner B G; Tilney N L; Kirkman R L; Milford E L; Cho S I; Bush H L; Levey A S; Strom T B; Carpenter C B
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.
Transplantation proceedings 1991;23(1 Pt 2):1357-60.
1991: Kupiec-Weglinski J W; Sablinski T; Hancock W W; Di Stefano R; Mariani G; Mix C T; Tilney N L
Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
Transplantation 1991;51(2):300-5.
1991: Sayegh M H; Sablinski T; Tanaka K; Kut J P; Kwok C A; Tilney N L; Kupiec-Weglinski J W; Milford E L
Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment.
Transplantation 1991;51(2):296-9.
1991: Kirkman R L; Shapiro M E; Carpenter C B; McKay D B; Milford E L; Ramos E L; Tilney N L; Waldmann T A; Zimmerman C E; Strom T B
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Transplantation 1991;51(1):107-13.
1991: Sablinski T; Sayegh M H; Hancock W W; Kut J P; Kwok C A; Milford E L; Tilney N L; Kupiec-Weglinski J W
Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection.
Transplantation 1991;51(1):226-31.
1990: Ueda H; Hancock W W; Cheung Y C; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
Transplantation 1990;50(4):545-50.
1990: Tanaka K; Tilney N L; Stunkel K G; Hancock W W; Diamantstein T; Kupiec-Weglinski J W
Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(19):7375-9.
1990: Tanaka K; Turka L A; Kupiec-Weglinski J W; Milford E L; Ueda H; Diamantstein T; Carpenter C B; Tilney N L
Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
Transplantation 1990;50(1):125-31.
1990: Ueda H; Hancock W W; Cheung Y C; Tanaka K; Kupiec-Weglinski J W; Tilney N L
Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
Transplantation 1990;49(6):1124-9.
1989: Tanaka K; Hancock W W; Osawa H; Stunkel K G; Alberghini T V; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(9):2873-9.
1989: Towpik E; Tilney N L
Harvey Cushing and his books.
Surgery, gynecology & obstetrics 1989;169(4):366-70.
1989: Kupiec-Weglinski J W; Mariani G; Tanaka K; Di Stefano R; Stünkel K G; Diamantstein T; Tilney N L
Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
Cellular immunology 1989;123(1):148-57.
1989: Ramos E L; Milford E L; Kirkman R L; Tilney N L; Strom T B; Shapiro M E; Waldmann T A; Wood I G; Rollins M R; Carpenter C B
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.
Transplantation 1989;48(3):415-20.
1989: Kupiec-Weglinski J W; Tilney N L
Lymphocyte migration patterns in organ allograft recipients.
Immunological reviews 1989;108():63-82.
1989: Kirkman R L; Shapiro M E; Carpenter C B; Milford E L; Ramos E L; Tilney N L; Waldmann T A; Zimmerman C E; Strom T B
Early experience with anti-Tac in clinical renal transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1766-8.
1989: DiSesa V J; Kirkman R L; Young P; Collins J J; Cohn L H; Tilney N L; Mudge G H
Successful management of catastrophic intraabdominal complications following cardiac transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2579-80.
1989: Araneda D; Padberg W M; Tilney N L
Refined techniques for heterotopic cardiac transplantation in the rat.
Transplantation proceedings 1989;21(1 Pt 3):2562.
1989: DiStefano R; Uhteg L C; Hancock W W; Araneda D; Kupiec-Weglinski J W; Tilney N L
Host-graft relationship in accelerated rejection of rat cardiac allografts.
Transplantation proceedings 1989;21(1 Pt 1):496-7.
1989: Lord R H; Padberg W M; Hancock W W; Kupiec-Weglinski J W; Tilney N L
Correlation of macrophage and NK cell numbers with "activation markers" in rat cardiac allografts.
Transplantation proceedings 1989;21(1 Pt 1):449-50.
1989: Tanaka K; Turka L A; Ueda H; Diamantstein T; Milford E L; Carpenter C B; Tilney N L; Kupiec-Weglinski J W
Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
Transplantation proceedings 1989;21(1 Pt 1):475-6.
1989: Tilney N L; Kupiec-Weglinski J W
Advances in the understanding of rejection mechanisms.
Transplantation proceedings 1989;21(1 Pt 1):10-3.
1989: Turka L A; Tanaka K; Kupiec-Weglinski J W; Milford E L; Tilney N L; Carpenter C B
In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats.
Transplantation 1989;47(2):388-90.
1989: Kupiec-Weglinski J W; van der Meide P; Stunkel K G; Tanaka K; Diamantstein T; Tilney N L
Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
Transplantation proceedings 1989;21(1 Pt 1):992-3.
1989: Kupiec-Weglinski J W; Tilney N L; Stunkel K G; Grutzmann R; van der Meide P H; Di Stefano R; Diamantstein T
Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
Transplantation 1989;47(1):11-6.
1989: Ramos E L; Leggat J E; Milford E L; Kirkman R L; Tilney N L; Strom T B; Shapiro M E; Waldmann T A; Carpenter C B
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.
Transactions of the Association of American Physicians 1989;102():231-9.
1989: Whitley D; Kupiec-Weglinski W; Tilney N L
Antibody-mediated rejection of organ grafts.
Current opinion in immunology 1989;2(6):864-9.
1988: Snydman D R; Werner B G; Tilney N L; Kirkman R L; Milford E L; Cho S I; Bush H L; Levey A S; Strom T B; Carpenter C B
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial.
Transplantation proceedings 1988;20(6 Suppl 8):24-30.
1988: Kupiec-Weglinski J W; Diamantstein T; Tilney N L
Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation.
Transplantation 1988;46(6):785-92.
1988: Tilney N L; Padberg W M; Lord R H; Araneda D; Strom T B; Kupiec-Weglinski J W
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipients.
Transplantation 1988;46(2 Suppl):122S-128S.
1988: Tilney N L; Strom T B; Kupiec-Weglinski J W
Pharmacologic and immunologic agonists and antagonists of cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 3):13-22.
1988: Padberg W M; Lord R H; Araneda D; Tilney N L; Kupiec-Weglinski J W
Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts.
Transplantation proceedings 1988;20(3 Suppl 3):1053-6.
1988: Thornburg L E; Padberg W M; Towpik E; Tilney N L
Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats.
Transplantation proceedings 1988;20(3 Suppl 3):1025-30.
1988: Di Stefano R; Mouzaki A; Araneda D; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.
The Journal of experimental medicine 1988;167(6):1981-6.
1988: Lord R H; Padberg W M; Di Stefano R; Hancock W W; Araneda D; Rickles F R; Tilney N L; Kupiec-Weglinski J W
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allografts.
Transplantation proceedings 1988;20(2):229-30.
1988: DiStefano R; Kupiec-Weglinski J W; Uhteg L C; Puskas J; Araneda D; Diamantstein T; Tilney N L
Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18.
Transplantation proceedings 1988;20(2 Suppl 2):217-22.
1988: DeCamp M M; Tilney N L
Late development of intractable lymphocele after renal transplantation.
Transplantation proceedings 1988;20(1):105-9.
1988: Kupiec-Weglinski J W; Di Stefano R; Stunkel K G; Grutzmann R; Theisen P; Araneda D; Tilney N L; Diamantstein T
Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
Transplantation proceedings 1988;20(1 Suppl 1):272-5.
1988: Padberg W M; Lord R H; Di Stefano R; Araneda D; Tilney N L; Kupiec-Weglinski J W
Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts.
Transplantation 1988;45(1):162-8.
1987: Tilney N L; Strom T B; Kupiec-Weglinski J W
Humoral and cellular mechanisms in acute allograft injury.
The Journal of pediatrics 1987;111(6 Pt 2):1000-3.
1987: Padberg W; Schwemmle K; Dobroschke J; Kupiec-Weglinski J W; Tilney N L
[Immunosuppressive therapy in transplantation surgery]
Deutsche medizinische Wochenschrift (1946) 1987;112(43):1670-4.
1987: Padberg W M; Di Stefano R; Lord R H; Araneda D; Strom T B; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation.
Transplantation proceedings 1987;19(5):4234-5.
1987: Snydman D R; Werner B G; Heinze-Lacey B; Berardi V P; Tilney N L; Kirkman R L; Milford E L; Cho S I; Bush H L; Levey A S
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
The New England journal of medicine 1987;317(17):1049-54.
1987: Padberg W M; Lord R H; Kupiec-Weglinski J W; Williams J M; Di Stefano R; Thornburg L E; Araneda D; Strom T B; Tilney N L
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(6):1751-7.
1987: Padberg W M; Kupiec-Weglinski J W; Lord R H; Araneda D H; Tilney N L
W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3669-74.
1987: Kupiec-Weglinski J W; Padberg W; Uhteg L C; Ma L; Lord R H; Araneda D; Strom T B; Diamantstein T; Tilney N L
Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
European journal of immunology 1987;17(3):313-9.
1987: Padberg W M; Kupiec-Weglinski J W; Lord R H; Towpik E; Tilney N L
W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients.
Transplantation proceedings 1987;19(1 Pt 1):493-4.
1987: Milford E L; Carpenter C B; Kirkman R L; Tilney N L; Mazoujian G; Strom T B; Lazarus J M; Schlossman S F; Guttmann R D; Lowry R
Anti-T12 monoclonal antibody therapy of acute renal allograft rejection.
Transplantation proceedings 1987;19(1 Pt 3):1910.
1987: Lord R H; Hancock W W; Colby A J; Padberg W; Diamantstein T; Kupiec-Weglinski J W; Tilney N L
Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
Transplantation proceedings 1987;19(1 Pt 1):354-5.
1987: Kupiec-Weglinski J W; Padberg W; Uhteg L C; Towpik E; Lord R H; Ma L; Diamantstein T; Strom T B; Tilney N L
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
Transplantation proceedings 1987;19(1 Pt 1):591-3.
1987: Towpik E; Kupiec-Weglinski J W; Uhteg L C; Padberg W; Tilney N L
Immune responsiveness following skin grafting in cyclosporine-treated rats.
Transplantation proceedings 1987;19(1 Pt 1):497-8.
1987: Hancock W W; Lord R H; Colby A J; Diamantstein T; Rickles F R; Dijkstra C; Hogg N; Tilney N L
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(1):164-70.
1986: Schneider T M; Kupiec-Weglinski J W; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom T B; Tilney N L
Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
Transplantation 1986;42(2):191-6.
1986: Schneider T M; Kupiec-Weglinski J W; Towpik E; Strom T B; Tilney N L
Studies on mechanisms of acute rejection of vascularized organ allografts.
Human immunology 1986;15(3):320-9.
1985: Towpik E; Kupiec-Weglinski J W; Schneider T M; Tyler D; Padberg W; Araneda D; Tilney N L
Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
Transplantation 1985;40(6):714-8.
1985: Kupiec-Weglinski J W; Towpik E; Schneider T M; Araneda D; Ma L; Tilney N L
T suppressor lymphocytes reverse ongoing acute allograft rejection.
Human immunology 1985;14(3):270-8.
1985: Heidecke C D; Araujo J L; Kupiec-Weglinski J W; Abbud-Filho M; Araneda D; Stadler J; Siewert J; Strom T B; Tilney N L
Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts.
Transplantation 1985;40(4):441-4.
1985: Araujo J L; Kupiec-Weglinski J W; Araneda D; Towpik E; Heidecke C D; Williams J M; Tilney N L
Phenotype, activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts.
Transplantation 1985;40(3):278-84.
1985: Kupiec-Weglinski J W; Heidecke C D; Araujo J L; Abbud-Filho M; Towpik E; Araneda D; Strom T B; Tilney N L
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
Cellular immunology 1985;93(1):168-77.
1984: Abbud-Filho M; Kupiec-Weglinski J W; Araujo J L; Heidecke C D; Tilney N L; Strom T B
Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
Journal of immunology (Baltimore, Md. : 1950) 1984;133(5):2582-6.
1984: Heidecke C D; Kupiec-Weglinski J W; Lear P A; Abbud-Filho M; Araujo J L; Araneda D; Strom T B; Tilney N L
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):582-8.
1984: Kupiec-Weglinski J W; Lear P A; Heidecke C D; Tilney N L
Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in rats.
Transplantation 1984;37(6):631-3.
1984: Kupiec-Weglinski J W; Lear P A; Heidecke C D; Araneda D; Tilney N L
Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection.
Cellular immunology 1984;85(2):459-76.
1984: Cho S I; Bradley J W; Monaco A P; Tilney N L
Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
American journal of surgery 1984;147(4):518-23.
1984: Tilney N L; Kupiec-Weglinski J W; Heidecke C D; Lear P A; Strom T B
Mechanisms of rejection and prolongation of vascularized organ allografts.
Immunological reviews 1984;77():185-216.
1983: Lear P A; Heidecke C D; Kupiec-Weglinski J W; Araneda D; Strom T B; Tilney N L
Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine.
Transplantation 1983;36(4):412-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nicholas Tilney

Research Profile (preview)

Physiology

Living Beings

Procedures

Chemicals & Drugs

Anatomy

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nicholas Tilney (preview)

All Publications